Company Overview: Suncorp Group Limited (ASX: SUN) provides insurance and banking products and services through various brands in Australia and New Zealand. Its segments include Insurance (Australia), Suncorp Bank and Suncorp New Zealand. Metcash Limited (ASX: MTS) is an Australian wholesale distribution and marketing company operating through the food, grocery, liquor, and hardware segments. IPH Limited (ASX: IPH) provides services related to the provision of filing, prosecution, enforcement as well as management of patents, designs, trademarks in Australia, New Zealand, Asia, and other countries. IPH is the holding company of AJ Park, Griffith Hack, Pizzeys, Smart & Biggar, Spruson & Ferguson and Applied Marks. APM Human Services International Limited (ASX: APM) is an international health and human services provider. Each financial year, APM supports more than 2 million people of all ages and stages of life from over 1,700 sites spanning 11 countries. Global specialty pharmaceutical group Clinuvel Pharmaceuticals Limited (ASX: CUV) is engaged in the development and commercialision of treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders. Kalkine’s Daily Report covers the Key Financial Metrics, Risks, Outlook, Technical Analysis along with the Valuation, Target Price, and Recommendation on the stock.

Suncorp Group Limited (ASX: SUN)

Section 1.0: Key Metrics in Pictures

Having looked at the key financial ratios above the below sections provide an in-depth fundamental, and technical analysis on this Insurance stock along with recommendations, technical support and resistance levels and indicative stop-loss.

Section 2.0: Suncorp Group Limited (‘Buy’ at AUD 13.850, closing market price as on 29 December 2023)

2.1 Company Details

2.2 Stock Recommendation, and Technical Guidance

The stock has increased by ~2.67% in 6 months and over the last 9 months, it has increased by ~14.37%. The stock has a 52-week low and 52-week high of AUD 11.455 and AUD 14.410, respectively and is currently trading above the average of 52-week high-low average.

Metcash Limited (ASX: MTS)

Section 1.0: Key Metrics in Pictures

Having looked at the key financial metrics above the below sections provide in-depth fundamental, and technical analysis on this Consumer Staples stock along with recommendation, technical support, and resistance level & indicative stop-loss.

Section 2.0: Metcash Limited (‘Buy’ at AUD 3.490 closing market price per share as on 29 December 2023)

2.1 Company Details

2.2 Valuation, Technical Summary & Stock Recommendation

The stock has witnessed a dip of ~7.6% in the last three months, and over the last one year, it has decreased by ~11.8%. The stock has a 52-week low and 52-week high of AUD 3.410 and AUD 4.240, respectively and is currently trading below the 52-week high-low average. MTS was last covered in a report dated ‘20 November 2023’.

IPH Limited (ASX: IPH) 

Section 1.0: Key Metrics in Pictures

Having looked at the key financial ratios above the below sections provide an in-depth fundamental, and technical analysis on this one ASX-listed Professional Services along with recommendations, technical support and resistance levels and indicative stop-loss.

Section 2.0: IPH Limited (‘Speculative Buy’ at AUD 6.410 closing market price per share as on 29 December 2023)

2.1 Company Details

2.2 Stock Recommendation and Valuation

The stock has witnessed a dip of ~13.5% in last three months, and over the last one year, it has decreased by ~26.6%. The stock has a 52-week low and 52-week high of AUD 6.325 and AUD 8.990, respectively and is currently trading below the 52-week high-low average. IPH was last covered in a report dated ’14 December 2023’.

APM Human Services International Limited (ASX: APM)

Section 1.0: Key Metrics in Pictures

Having looked at the key financial ratios above the below sections provide an in-depth fundamental, and technical analysis on this Professional Services’ stock along with recommendations, technical support and resistance levels and indicative stop-loss.

Section 2.0: APM Human Services International Ltd - (‘Speculative Buy’ at AUD 1.225, closing market price as on 29 December 2023)

Company Details

2.3 Stock Recommendation, and Technical Guidance

The stock has fallen around 19% in the last 1 month and plunged around 42% in the past 6 months. The stock has a 52-week low and 52-week high of AUD 1.080 and AUD 2.640, respectively and is currently trading below the average of 52-week high-low average. APM was last covered in a report dated ‘14 December 2023’.

 (Source: REFINTIV; Analysis by Kalkine Group)

Clinuvel Pharmaceuticals Limited (ASX: CUV)

Section 1.0: Key Metrics in Pictures

Having looked at the key financial metrics above the below sections provide in-depth fundamental, and technical analysis on this Biotechnology Stock along with recommendation, technical support, and resistance level & indicative stop-loss.

Section 2.0: Clinuvel Pharmaceuticals Limited (‘Speculative Buy’ at AUD 16.000 closing market price per share as on 29 December 2023)

2.2 Company Details

2.2 Valuation, Technical Summary & Stock Recommendation

The stock has witnessed a gain of ~8.7% in the last three months, and over the last one year, it has decreased by ~25.8%. The stock has a 52-week low and 52-week high of AUD 13.970 and AUD 28.720, respectively and is currently trading below the 52-week high-low average. CUV was last covered in a report dated ‘16 November 2023’.

Markets are trading in a highly volatile zone currently due to certain macro-economic and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 29 December 2023. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Dividend Yield may vary as per the stock price movement.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.

Disclaimer

Kalkine New Zealand Limited is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity financial products. The recommendations and opinions [on this website] / [in this report] do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine).  Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website.  Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.